Pune Investment：Listed company positive and negative news on Monday, April 8, 2024

Source: Snowball APP, Author: Wind Wancha, (

Hong Kong Wan De News Agency sort out positive news

———— major matters ————————

: Holding subsidiary MGI intends to introduce Indian local investors, and it is expected that the company's net profit will be 50-7 billion yuan.

: A joint laboratory of artificial intelligence with the Wuhan Academy of Peking University, using new technologies such as artificial intelligence and other new technologies to empower the digital intelligence capabilities of Kyushu Tongchain pharmaceutical industry comprehensive service providers, and in -depth cooperation to create artificial intelligence and products.

: All -funded subsidiary signed a computing power cooperation service framework agreement.

: From January to March, the sales volume of Changan cars increased by 13.87%year-on-year; independent brands sold 588,800 units, an increase of 13.57%year-on-year.

———— performance growth ——————————

: In the first quarter, net profit increased by 199%to 254%year -on -year. During the reporting period, a new shingle -shaped toxic vaccine product was added compared with the same period of the previous year, which enriched the company's vaccine type and promoted the overall income of the company.The gross profit margin of shingles to reduce the live vaccine is high, helping the company's performance increase year -on -year.

: It is expected that net profit in the first quarter will increase by 30%-80%year -on -year.

: In 2023, net profit increased by 11.36%year -on -year, and it was planned to be 15.9784 yuan.

: In 2023, net profit increased by 13.09%year -on -year, and it was planned to be 3.1 yuan.

: In 2023, net profit increased by 7.57%year -on -year, and it was planned to be 6.8 yuan.

: In 2023, the net profit was 397 million yuan, a year -on -year loss, and it was planned to be 1 yuan.

Atlantic: The net profit of 2023 was 101 million yuan, an increase of 48.81%year -on -year, and it was planned to be 0.55 yuan.

———— Financing Reorganization ——————

ST large collection: The actual controller is officially changed to the National Supply and Marketing Cooperative of China.

: Holding subsidiary Zhongning Silicon Industry plans to apply for listing on the New Third Board.

——— Investment mergers and acquisitions ————————

: Subsidies intend to increase capital Huadian Harbin Bayan Co., Ltd..

: The subsidiary intends to set up a partnership company to purchase 6%equity of Guangdong Shengyang Huachuang Technology Co., Ltd..

: It is planned to buy 75%equity of Fubang Industrial.

Shandong High -speed: It is planned to acquire 20%equity of Luzhou Southeast Company.

——— Equity transfer —————————

: It is planned to transfer 100%equity of Beijing Taiyong to Huang Xiaohua at 500,000 yuan.

: Yuehe Assets intends to transfer 4.03%of the shares to the Provincial Supply and Marketing Group.

: Nanning Futian plans to transfer 5.54%of Nanning's production investment.

———— Business Business ————————

: Notice of the approval of clinical trials of the Somemarccum Mibabu.

: Nimai Kok Forest Film received a drug registration certificate.

Yipinhong: Holding subsidiary and signing the "Technical Services (Commission) Contract".

: Shu Wozhe's first -line treatment of EGFR20 outer appetite inserted mutant -variable advanced non -small cell lung cancer was identified by the US FDA breakthrough therapy.

: Notice of approval of clinical trials of drugs.Pune Investment

: Voltazole injection is permitted by the Swedish Drug Administration.

: Tripley Mippling Application for the listing of new indications for the treatment of renal cell carcinoma is approved.

——— Bid -winning contract —————————

: Receive the fixed point notice.

: Holding subsidiaries signed multiple contracts with the affiliated service company.

: Pre -bid for sanitation operations and green management of Chongqing Fengjie County (Samma Mountain area).Jaipur Investment

: The subsidiary obtained the notice of the finalist of the bid.

: The subsidiary won the project of 1.081 billion yuan in projects.

: Pre -mid -to -medium bid for about 322 million yuan of national power grid procurement projects.

: Pre -mid -to -China Standard of approximately 161 million yuan of national power grid procurement projects.

: The subsidiary jointly won the 9.881 billion yuan project.

———— increase holding repurchase ————————

: It is planned to repurchase the company's shares for 30 million-60 million yuan.Negative news

———— major matters ————————

: The company's founder and former chairman Wu Lizhen, resigned with the world on April 4, 2024 at the age of 83.Wu Lizhen's death will not cause substantial changes in the company's actual controllers.

: The US FDA issued import warnings to the adoption of medical treatment. Before adopting medical care, the medical syringe products adopted by some medical syringes will not be temporarily unable to enter the US market. It is expected that the company's subsequent business income and profits will have a significant impact.

: The suspension of some drilling platform operations this time is due to the adjustment of the customer operation plan. At present, the company still has multiple drilling platforms to provide services normally in the area.The company currently operates a total of 62 drilling platforms. The suspension of this platform operation has a small impact on the company's drilling sector.

: On April 4, the company received the "Reserve Notice" and "Notice of File C case" issued by the National Supervision Commission to implement the reservation of the company's actual controller, chairman and general manager of the company.As of the disclosure of this announcement, the company's production and operation conditions were normal.

: Deng Guanhua, chairman and general manager of the company, was investigated and implemented for suspected disciplinary violations.

———This performance decline ——————————————

Atlantic: The net profit of 2023 was 101 million yuan, an increase of 48.81%year -on -year, and it was planned to be 0.55 yuan.

: In 2023, net profit decreased by 3%year -on -year, and it was planned to be 1.6 yuan.

: In 2023, a net loss was 342 million yuan, a year -on -year loss.

: In 2023, a net loss was 1.673 billion yuan.

——————————————

: Two shareholders do not exceed 3%of the shares.

: Dazheng Group's self -reduced holdings of not exceeding 1%of the shares.

: Rao Wei, director and senior vice president, intends to reduce its holdings of not more than 163,600 shares.

———— Risk Tips —————

: Holding subsidiaries have become authorized partners of the 1S store.

Ahmedabad Stock